Publications by authors named "Ying X Gue"

Claim this Profile
A
A Comparative Analysis of Cardiovascular Events Associated With Acalabrutinib Versus Ibrutinib in Chronic Lymphocytic Leukemia: Insights From a Global Federated Network.
Abdulrahman Majrashi, Ying X Gue, Alena Shantsila, Stella Williams, Catrin Tudur Smith

Pharmacol Res Perspect· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Heart Failure Team on Inpatient Rapid Sequencing of Heart Failure Therapy.
Zhongrui Zhou, Khalid Kardas, Ying Xuan Gue, Ali Najm, Anas Tirawi

J Cardiovasc Dev Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Cardiotoxicity of Ibrutinib Versus Chemoimmunotherapy in Chronic Lymphocytic Leukemia: A Population-Based Study.
Abdulrahman Majrashi, Ying X Gue, Alena Shantsila, Stella Williams, Gregory Y H Lip

J Clin Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular and metabolic effects of ovarian suppression in combination with tamoxifen or an aromatase inhibitor as adjuvant therapy for early oestrogen receptor-positive breast cancer: a systematic review.
Ying X Gue, Dorothy Lau, Alena Shantsila, Gregory Y H Lip, Carlo Palmieri

Arch Med Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethnic Differences in Thrombotic Profiles of Acute Coronary Syndrome Patients and Relationship to Cardiovascular Outcomes: A Comparison of East Asian and White subjects.
Jung-Won Suh, Vassilios Memtsas, Ying X Gue, Hyoung-Won Cho, Wonjae Lee

Thromb Haemost· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of very low dose rivaroxaban in addition to dual antiplatelet therapy on endogenous fibrinolysis in acute coronary syndrome: The VaLiDate-R study.
Ying X Gue, Vassilios Memtsas, Rahim Kanji, David M Wellsted, Amanda Busby

Thromb Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematologic Malignancies and Increased Cardiovascular Risk-Can More Be Done to Mitigate?
Ying X Gue, Gregory Y H Lip

Am J Cardiol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased risk of venous thromboembolism in patients with gastrointestinal disorders.
Ying X Gue, Gregory Y H Lip

Am J Hematol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete revascularization in elderly patients with myocardial infarction-a safe, effective, and necessary strategy?
Ying X Gue, Gregory Y H Lip

Cell Rep Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers of Thrombotic Status Predict Spontaneous Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction.
Rahim Kanji, Ying X Gue, Vassilios Memtsas, Neil H Spencer, Diana A Gorog

J Am Coll Cardiol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-analysis Comparing Long-Term Clinical Outcomes of Percutaneous Coronary Intervention versus no Intervention in Patients with Chronic Total Occlusion.
Abdalazeem Ibrahem, Mohamed Farag, Ying X Gue, Nikolaos Spinthakis, Ayman Al-Atta

Heart Views· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous Reperfusion in Patients with Transient ST-Elevation Myocardial Infarction-Prevalence, Importance and Approaches to Management.
Mohamed Farag, Marta Peverelli, Nikolaos Spinthakis, Ying X Gue, Mohaned Egred

Cardiovasc Drugs Ther· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society.
Diana A Gorog, Ying X Gue, Tze-Fan Chao, Laurent Fauchier, Jose Luis Ferreiro

Europace· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of Endogenous Fibrinolysis in Whole Blood Under High Shear in Patients With Myocardial Infarction.
Rahim Kanji, Ying X Gue, Mohamed F Farag, Neil H Spencer, Nicola J Mutch

JACC Basic Transl Sci· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper.
Diana A Gorog, Ying X Gue, Tze-Fan Chao, Laurent Fauchier, Jose Luis Ferreiro

Thromb Haemost· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factor XIa Inhibition: Is It a Novel Alternative Antithrombotic Strategy for High-Risk ACS Patients?
Ying X Gue, Diana A Gorog, Gregory Y H Lip

Circulation· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease: Does Less Mean More?
Ying X Gue, Diana A Gorog, Gregory Y H Lip

JAMA Cardiol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the ESC/EACTS 2020 Atrial Fibrillation Guidelines With Perioperative Implications.
James A Nelson, Ying X Gue, Jon M Christensen, Gregory Y H Lip, Harish Ramakrishna

J Cardiothorac Vasc Anesth· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer and incident cardiovascular events: A systematic analysis at the nationwide level.
Ying X Gue, Arnaud Bisson, Alexandre Bodin, Julien Herbert, Gregory Y H Lip

Eur J Clin Invest· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Season of Birth and Cardiovascular Mortality in Atrial Fibrillation: A Population-Based Cohort Study.
Ying X Gue, Arnaud Bisson, Alexandre Bodin, Julien Herbert, Gregory Y H Lip

J Cardiovasc Dev Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crizanlizumab: A CRITICAL Drug During a CRITICAL Time?
Ying X Gue, Giordano Pula, Gregory Y H Lip

JACC Basic Transl Sci· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photoplethysmography rhythm interpretation: an essential skill in an era of novel technologies.
Ying X Gue, Wahbi K El-Bouri, Gregory Y H Lip

Eur Heart J Digit Health· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'Rise of the machines': the next frontier in individualized medicine.
Wahbi K El-Bouri, Ying X Gue, Gregory Y H Lip

Cardiovasc Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypertension and atrial fibrillation: Closing a virtuous circle.
Ying X Gue, Gregory Y H Lip

PLoS Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrinolysis in Platelet Thrombi.
Rahim Kanji, Ying X Gue, Vassilios Memtsas, Diana A Gorog

Int J Mol Sci· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis